Weekly shot tested for rare lung disease
Disease control
Completed
This study tested the safety of two different doses of a weekly injection for people with Alpha-1 Antitrypsin Deficiency, a genetic condition that can cause lung disease. Seventeen adults with moderate lung impairment received the injections under the skin for eight weeks. The ma…
Phase: PHASE1, PHASE2 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC